12/22/2025
Florida just quietly changed the game on GLP-1s.
Most clinics haven’t realized it yet.
This isn’t about molecules.
It’s not about marketing angles.
And it’s definitely not about “who has the cheapest compound.”
The real shift is this:
Florida is squeezing the middle.
• Compounding access is getting tighter
• Pharmacy relationships are becoming more fragile
• Compliance risk is rising for clinics that bolted GLPs onto old models
• “Just offer injections” is no longer a strategy
What’s emerging is a clear split.
Clinics with:
✔️ Clean medical oversight
✔️ Tight intake + documentation
✔️ Real operational ownership of the program
…will scale.
Clinics running GLPs as a side hustle inside a chaotic operation will feel pain first.
This creates short-term opportunity and long-term consequences.
Short term:
• Clinics need clarity fast
• Programs need to be restructured, not paused
• Owners need to know what’s exposed and what’s not
Long term:
• GLPs become a real service line
• Or they disappear from your clinic entirely
This is one of those moments where doing nothing is still a decision.
If you’re operating in Florida and offering GLP-1s right now:
What’s your biggest concern?
• Compliance
• Pharmacy continuity
• Program margin
• Or operational strain